These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 18791417)
1. Evaluation of ovarian tumors by proton magnetic resonance spectroscopy at three Tesla. Stanwell P; Russell P; Carter J; Pather S; Heintze S; Mountford C Invest Radiol; 2008 Oct; 43(10):745-51. PubMed ID: 18791417 [TBL] [Abstract][Full Text] [Related]
2. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience. Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465 [TBL] [Abstract][Full Text] [Related]
3. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors. Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615 [TBL] [Abstract][Full Text] [Related]
5. 1H magnetic resonance spectroscopy of invasive cervical cancer: an in vivo study with ex vivo corroboration. Mahon MM; Williams AD; Soutter WP; Cox IJ; McIndoe GA; Coutts GA; Dina R; deSouza NM NMR Biomed; 2004 Feb; 17(1):1-9. PubMed ID: 15011245 [TBL] [Abstract][Full Text] [Related]
6. Detection of human immunodeficiency virus induced inflammation and oxidative stress in lenticular nuclei with magnetic resonance spectroscopy despite antiretroviral therapy. Roc AC; Ances BM; Chawla S; Korczykowski M; Wolf RL; Kolson DL; Detre JA; Poptani H Arch Neurol; 2007 Sep; 64(9):1249-57. PubMed ID: 17620480 [TBL] [Abstract][Full Text] [Related]
7. Preliminary study of proton magnetic resonance spectroscopy in bone and soft tissue tumors: an unassigned signal at 2.0-2.1 ppm may be a possible indicator of malignant neuroectodermal tumor. Oya N; Aoki J; Shinozaki T; Watanabe H; Takagishi K; Endo K Radiat Med; 2000; 18(3):193-8. PubMed ID: 10972550 [TBL] [Abstract][Full Text] [Related]
8. 3D 1H MRSI of brain tumors at 3.0 Tesla using an eight-channel phased-array head coil. Osorio JA; Ozturk-Isik E; Xu D; Cha S; Chang S; Berger MS; Vigneron DB; Nelson SJ J Magn Reson Imaging; 2007 Jul; 26(1):23-30. PubMed ID: 17659562 [TBL] [Abstract][Full Text] [Related]
9. Single voxel proton MR spectroscopy findings of typical and atypical intracranial meningiomas. Demir MK; Iplikcioglu AC; Dincer A; Arslan M; Sav A Eur J Radiol; 2006 Oct; 60(1):48-55. PubMed ID: 16844335 [TBL] [Abstract][Full Text] [Related]
10. Preliminary assessment of benign maxillofacial and neck lesions with in vivo single-voxel 1H magnetic resonance spectroscopy. Yu Q; Yang J; Wang P; Shi H; Luo J Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):264-70. PubMed ID: 17630099 [TBL] [Abstract][Full Text] [Related]
11. N-acetyl resonances in in vivo and in vitro NMR spectroscopy of cystic ovarian tumors. Kolwijck E; Engelke UF; van der Graaf M; Heerschap A; Blom HJ; Hadfoune M; Buurman WA; Massuger LF; Wevers RA NMR Biomed; 2009 Dec; 22(10):1093-9. PubMed ID: 19593761 [TBL] [Abstract][Full Text] [Related]
12. Ex vivo proton MR spectroscopy (1H-MRS) for evaluation of human gastric carcinoma. Mun CW; Cho JY; Shin WJ; Choi KS; Eun CK; Cha SS; Lee J; Yang YI; Nam SH; Kim J; Lee SY Magn Reson Imaging; 2004 Jul; 22(6):861-70. PubMed ID: 15234456 [TBL] [Abstract][Full Text] [Related]
13. In vivo magnetic resonance spectroscopy of gynaecological tumours at 3.0 Tesla. Booth SJ; Pickles MD; Turnbull LW BJOG; 2009 Jan; 116(2):300-3. PubMed ID: 19076962 [TBL] [Abstract][Full Text] [Related]
14. Considerations in applying 3D PRESS H-1 brain MRSI with an eight-channel phased-array coil at 3 T. Li Y; Osorio JA; Ozturk-Isik E; Chen AP; Xu D; Crane JC; Cha S; Chang S; Berger MS; Vigneron DB; Nelson SJ Magn Reson Imaging; 2006 Dec; 24(10):1295-302. PubMed ID: 17145400 [TBL] [Abstract][Full Text] [Related]
15. Temporal window of metabolic brain vulnerability to concussion: a pilot 1H-magnetic resonance spectroscopic study in concussed athletes--part III. Vagnozzi R; Signoretti S; Tavazzi B; Floris R; Ludovici A; Marziali S; Tarascio G; Amorini AM; Di Pietro V; Delfini R; Lazzarino G Neurosurgery; 2008 Jun; 62(6):1286-95; discussion 1295-6. PubMed ID: 18824995 [TBL] [Abstract][Full Text] [Related]
16. Characterization of bone and soft-tissue tumors with in vivo 1H MR spectroscopy: initial results. Wang CK; Li CW; Hsieh TJ; Chien SH; Liu GC; Tsai KB Radiology; 2004 Aug; 232(2):599-605. PubMed ID: 15286325 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values. Senft C; Hattingen E; Pilatus U; Franz K; Schänzer A; Lanfermann H; Seifert V; Gasser T Neurosurgery; 2009 Nov; 65(5):908-13; discussion 913. PubMed ID: 19834403 [TBL] [Abstract][Full Text] [Related]
18. Human cervical lymphadenopathy: evaluation with in vivo 1H-MRS at 1.5 T. King AD; Yeung DK; Ahuja AT; Yuen EH; Ho SF; Tse GM; van Hasselt AC Clin Radiol; 2005 May; 60(5):592-8. PubMed ID: 15851048 [TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging and spectroscopy of pilomyxoid astrocytomas: case reports and comparison with pilocytic astrocytomas. Morales H; Kwock L; Castillo M J Comput Assist Tomogr; 2007; 31(5):682-7. PubMed ID: 17895777 [TBL] [Abstract][Full Text] [Related]
20. Improved preoperative evaluation of cerebral cavernomas by high-field, high-resolution susceptibility-weighted magnetic resonance imaging at 3 Tesla: comparison with standard (1.5 T) magnetic resonance imaging and correlation with histopathological findings--preliminary results. Pinker K; Stavrou I; Szomolanyi P; Hoeftberger R; Weber M; Stadlbauer A; Noebauer-Huhmann IM; Knosp E; Trattnig S Invest Radiol; 2007 Jun; 42(6):346-51. PubMed ID: 17507804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]